News
Important Only
Lilly signs up to $1.93 billion deal with Repertoire for autoimmune therapies
Jan 29 (Reuters) - Drugmaker Eli Lilly LLY.N is partnering with Repertoire Immune Medicines in a deal worth up to $1.93 billion to develop therapies for multiple autoimmune diseases, the Massachusetts-based biotech said on Thursday.Repertoire will receive $85 million upfront and up to $1.84 billion ...Reuters
Thu, Jan 29
Chechen leader Kadyrov says Russia should fight war in Ukraine to the end
MOSCOW, Jan 29 (Reuters) - The leader of Russia's Chechnya region, Ramzan Kadyrov, said on Thursday that he was opposed to talks on ending the war in Ukraine and that Moscow should fight on."I believe the war must be taken to its conclusion... I am against negotiations," Kadyrov told rep...Reuters
Thu, Jan 29
Brunswick Q4 revenue beats on strong OEM orders
OverviewMarine recreation firm's Q4 revenue rose 16%, beating analyst expectationsAdjusted EPS for Q4 increased 141.7% yr/yr, reflecting operational improvementsCompany's propulsion segment reported 23% sales increase, boosting overall performanceOutlookBrunswick projects 2026 net sales betw...Reuters
Thu, Jan 29
ICE ends enhanced enforcement activities in Maine, US senator says
WASHINGTON, Jan 29 (Reuters) - Immigration and Customs Enforcement has ended its enhanced operations in Maine, its Republican U.S. Senator Susan Collins said on Thursday, citing a conversation with the head of the Department of Homeland Security. "I can report that Secretary (Kristi) Noem has in...Reuters
Thu, Jan 29
INSIGHT-Trump weighs Iran strikes to inspire renewed protests, sources say
Trump's options include targeting leaders and security forces involved in crackdown, US sources say Strikes on nuclear or missile programmes also considered: sources Trump has not decided whether to take military path, sources sayIran prepares for military confrontation, seeks diplomatic channel...Reuters
Thu, Jan 29
China relaxes visa rules for UK citizens on PM's trip to Beijing
BEIJING, Jan 29 (Reuters) - China agreed to relax rules to allow some visa-free travel for British citizens on Thursday during a visit by Prime Minister Keir Starmer to Beijing, as part of a partnership deal which London hopes will help expand its service sector. British citizens will be allowed...Reuters
Thu, Jan 29
Minnesota Governor Walz rules out running for elective office, saying 'never again'
Walz says he will never run for elective office againWalz had earlier left open the option of another officeBy Brad Brooks MINNEAPOLIS, Jan 28 (Reuters) - Minnesota Governor Tim Walz, describing himself as a political "lightning rod," said on Wednesday he would never run for elective offi...Reuters
Thu, Jan 29
Honeywell Q4 profit beats on strong aerospace demand
OverviewDiversified technology firm's Q4 adjusted EPS beat analyst expectationsCompany's Q4 adjusted sales rose 10%, driven by Aerospace and Building AutomationHoneywell Aerospace spin-off expected in Q3 2026OutlookHoneywell expects 2026 adjusted EPS of $10.35 to $10.65, up 6% to 9%Company a...Reuters
Thu, Jan 29
Designer Brands Inc - On Jan 28, Court Issues Temporary Restraining Order Against Worldpay - SEC Filing
Jan 29 (Reuters) - Designer Brands Inc DBI.N:DESIGNER BRANDS INC - ON JAN 28, COURT ISSUES TEMPORARY RESTRAINING ORDER AGAINST WORLDPAY - SEC FILINGDESIGNER BRANDS INC: COURT FOUND CO IS "MORE LIKELY THAN NOT TO SUCCEED ON MERITS OF ITS CLAIM FOR BREACH OF CONTRACT AND DECLARATORY RELIEF"DES...Reuters
Thu, Jan 29
Dow's Q4 net sales fall on price declines, lower volumes
OverviewMaterials science company's Q4 net sales fell 9% yr/yr to $9.5 blnAdjusted EPS for Q4 was a loss, but beat analyst expectationsCompany faced price declines and lower operating rates, partly offset by cost reductionsOutlookDow expects Transform to Outperform to deliver $2 bln in additiona...Reuters
Thu, Jan 29
Thermo Fisher Q4 revenue, profit beat estimates
OverviewScience services leader's Q4 revenue grew 7%, beating analyst expectationsAdjusted EPS for Q4 beat analyst expectationsCompany completed acquisitions to enhance bioproduction and clinical trial capabilitiesOutlookCompany will provide 2026 financial guidance during its earnings conference...Reuters
Thu, Jan 29
Advanced Flower Capital Enters Credit Agreement With TCGSL LLC - SEC Filing
Jan 29 (Reuters) - Advanced Flower Capital Inc AFCG.O:ADVANCED FLOWER CAPITAL INC - ENTERS CREDIT AGREEMENT WITH TCGSL LLC - SEC FILINGADVANCED FLOWER CAPITAL INC - CREDIT AGREEMENT PROVIDES $20 MILLION COMMITMENT, MATURES AUGUST 2028 - SEC FILINGSource text: [ID:n0001829126-26-000724]Reuters
Thu, Jan 29
